We are live on ! Find out more
BMRN icon

BioMarin Pharmaceuticals
BMRN

280 hedge funds and large institutions have $7.98B invested in BioMarin Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 280 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less call options, than puts

Call options by funds: $36.2M | Put options by funds: $43M

Holders
280
Holders Change
+280
Holders Change %
–
% of All Funds
9.14%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
280
Increased
–
Reduced
–
Closed
–
Calls
$36.2M
Puts
$43M
Net Calls
-$6.77M
Net Calls Change
-$6.77M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
51
BlackRock Advisors
Delaware
$27.4M +$30.6M +491,306 New
BG
52
BlackRock Group
United Kingdom
$27M +$30.2M +485,058 New
TA
53
Teachers Advisors
New York
$25.9M +$28.9M +463,380 New
ZDA
54
Zweig-DiMenna Associates
New York
$25.4M +$28.4M +455,692 New
ClearBridge Investments
55
ClearBridge Investments
New York
$25M +$27.9M +448,346 New
TI
56
Turner Investments
Pennsylvania
$23.5M +$26.3M +421,939 New
RIM
57
RS Investment Management
California
$20.3M +$22.7M +364,570 New
AG
58
Artal Group
Luxembourg
$19.5M +$21.8M +350,000 New
California Public Employees Retirement System
59
California Public Employees Retirement System
California
$19M +$21.2M +340,371 New
Sumitomo Mitsui Trust Group
60
Sumitomo Mitsui Trust Group
Japan
$18M +$20.1M +322,287 New
NTCOC
61
Northern Trust Company of Connecticut
Connecticut
$17.4M +$19.4M +312,040 New
Neuberger Berman Group
62
Neuberger Berman Group
New York
$14.7M +$16.4M +263,535 New
MCM
63
Marsico Capital Management
Colorado
$14.5M +$16.2M +259,319 New
Lord, Abbett & Co
64
Lord, Abbett & Co
New Jersey
$13.9M +$15.5M +248,710 New
DM
65
Deerfield Management
New York
$13.8M +$15.4M +247,000 New
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$13.5M +$15.1M +242,236 New
Fidelity International
67
Fidelity International
Bermuda
$13.3M +$14.9M +238,902 New
Millennium Management
68
Millennium Management
New York
$13.3M +$14.8M +238,165 New
CIP
69
Chartwell Investment Partners
Pennsylvania
$13.1M +$14.7M +235,625 New
PAMU
70
Pictet Asset Management (UK)
United Kingdom
$13.1M +$14.6M +235,006 New
Mitsubishi UFJ Trust & Banking
71
Mitsubishi UFJ Trust & Banking
Japan
$13M +$14.5M +232,390 New
VanEck Associates
72
VanEck Associates
New York
$12.6M +$14.1M +225,874 New
State Board of Administration of Florida Retirement System
73
State Board of Administration of Florida Retirement System
Florida
$12.2M +$13.6M +218,679 New
HIM
74
Hermes Investment Management
United Kingdom
$12.1M +$13.5M +216,910 New
FWIA
75
Fort Washington Investment Advisors
Ohio
$11.7M +$13.1M +209,466 New
1 2
3
4 5

BMRN Hedge Fund Activity: Q2 2013 in Review

280 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in BioMarin Pharmaceuticals (BMRN) for Q2 2013, worth a combined $7.98B.

Buyers outnumbered sellers: 280 funds opened new BMRN positions and 0 closed out — a net gain of 280 holders — while 0 added to existing stakes and 0 trimmed.

  • 280 institutional investors held BioMarin Pharmaceuticals (BMRN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $7.98B of BioMarin Pharmaceuticals stock for Q2 2013.
  • 280 funds opened new BioMarin Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +280 holders.

Based on aggregated 13F filings for Q2 2013.